CAS Name: androst-4-en-3-one, 17-[(1-oxoheptyl)-oxy]-, (17β)-
Testosterone enanthate injection USP, provides testosterone enanthate, a derivative of the primary endogenous androgen testosterone, for intramuscular administration. In their active form, androgens have a 17-beta-hydroxy group. Esterification of the 17-beta-hydroxy group increases the duration of action of testosterone; hydrolysis to free testosterone occurs in vivo. Testosterone esters are less polar than free testosterone. Testosterone esters in oil injected intramuscularly are absorbed slowly from the lipid phase; thus Testosterone Enanthate can be given at intervals of two to four weeks.
Testosterone enanthate used in males to treat primary hypogonadism (congenital or acquired) – testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy. In females: metastatic mammary cancer. Other methods of counteracting estrogen activity in cases of adrenalectomy, hypophysectomy, and/or antiestrogen therapy.
|each mL contains:|
|Testosterone Enanthate||USP||250 mg|
|Benzyl Alcohol||BP||3.0% v/v|
Packing: 10 mL Glass Vial
Post Footer automatically generated by Add Post Footer Plugin for wordpress.Tweet